Abdallah El-Husseiny Mahmoud, Abdel-Moneim Ashraf Abdel-Hameed, Abdel-Maksoud Mohammed Arafat, Hammad Kamel Suliman
Department of Surgery, Al-Azhar University, Cairo, Egypt.
Department of Surgery, Al-Azhar University, Cairo, Egypt.
Diabetes Metab Syndr. 2018 Jul;12(4):491-495. doi: 10.1016/j.dsx.2018.03.010. Epub 2018 Mar 16.
The study was performed to evaluate the technique of laproscopic minigastric bypass for metabolic syndrome patients.
The patients were enrolled in a combined prospective study and had a retrospectively gathered outcome analysis.
The study includes thirty patients; 24 females and 6 males suffering from metabolic syndrome with a mean age of 33.15 ± 10.17 years (range, 20-59), who fulfilled the criteria for bariatric surgery with BMI >35 with associated co-morbidities, all patients underwent laparoscopic mini-gastric bypass.
BMI and WC were significantly reduced post-operatively; also co-morbidities as DM, hypertension and dyslipidemia were resolved or controlled. The mean operative time was 90 ± 12.6 min (range, 80-120). No mortality was reported within 30 days of surgery.
Laparoscopic mini gastric bypass is an effective procedure for the treatment of obesity, HTN, type 2 DM and dyslipidemia, technically feasible, safe operation with a low rate of major postoperative complications.
本研究旨在评估腹腔镜迷你胃旁路手术治疗代谢综合征患者的技术。
患者纳入一项前瞻性联合研究，并进行回顾性收集的结果分析。
本研究包括30例患者，其中24例女性和6例男性患有代谢综合征，平均年龄33.15±10.17岁（范围20 - 59岁），符合BMI>35且伴有相关合并症的减重手术标准，所有患者均接受腹腔镜迷你胃旁路手术。
术后BMI和腰围显著降低；糖尿病、高血压和血脂异常等合并症也得到缓解或控制。平均手术时间为90±12.6分钟（范围80 - 120分钟）。术后30天内无死亡报告。
腹腔镜迷你胃旁路手术是治疗肥胖、高血压、2型糖尿病和血脂异常的有效方法，技术上可行，手术安全，术后主要并发症发生率低。
